Europe Virus-like Particles Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Hepatitis, Cancer/HPV, and Gaucher disease), Source (Yeast, Insect Cell, Plant, and Others), and Application (Vaccines and Therapeutics)

Name: Europe Virus-like Particles Market
SKU: Pharmaceuticals
Rating: 4.3 (71 reviews)

Market Introduction

Europe comprises five prominent countries, namely Germany, France, UK, Italy, and Spain. The market also comprises the rest of the countries in Europe. Europe's virus-like particles market is witnessing stronger growth due to new product approvals by the authorized bodies. For example, the first licensed malaria VLP based vaccine namely, "Mosquirix," was approved by the European regulators. In addition, countries like the UK, Germany, France, Italy, and Spain are the key contributing countries driving the demand for virus-like particles products in Europe.

As per the World Health Organization (WHO) report, currently, every single country in Europe is facing a real threat of COVID-19. The pace of virus transmission across the 53 countries of the WHO European Region is a matter of concern. To control the transmission, countries of Europe are conducting vaccination roll-outs at various stages. In Europe, various COVID-19 vaccines are currently being developed and are in clinical trials, in the countries such as the UK, Germany, and Russia. Among them, there are three vaccines in the UK, three vaccines in Germany, and 2 in Russia. Among these vaccines, there is one inactivated vaccine, two protein subunits, three viral vector vaccines, and two nucleic acid vaccines. To combat the coronavirus in the European region, Europe as a whole has made consistent efforts to drive vaccine development. The Bruegel report states that, prior to the COVID-19 pandemic, the EU announced funding of almost US$500 Million for vaccine and vaccination research through the Horizon 2020 research program during 2014-2020. Additionally, to combat COVID-19, the EU has offered emergency funds to support research and development for diagnostics, therapeutics, and vaccines. Initially, US$10 Million subsequently increased to US$ 47.5 Million and was allotted for research projects for responding to the COVID-19 pandemic. Moreover, the European Institute of Technology Health opened in April 2020 was a call to EIT partners to send proposals for COVID-19 projects with robust implementation with funding of each project.

Get more information on this report :

Market Overview and Dynamics

The virus-like particles market in Europe is expected to grow from US$ 1,302.03 million in 2021 to US$ 2,203.61 million by 2028; it is estimated to grow at a CAGR of 7.8% from 2021 to 2028. Vaccines form one of the significant segments of the pharmaceuticals industry. They have an extensive application in the immunization of humans and animals against common infections. Companies operating in the pharmaceuticals and biopharmaceuticals markets continuously focus on product innovations and developments to sustain competition in the market. For instance, the market players have been significantly investing in the development of vaccines against COVID-19 and studies related to VLP. The active developments by life sciences companies, coupled with government support for the same, is contributing to the VLP market growth.

Key Market Segments

In terms of product type, the hepatitis segment accounted for the largest share of the Europe virus-like particles market in 2021. In terms of source, the yeast segment accounted for the largest share of the Europe virus-like particles market in 2021. In term of application, vaccines segment held a larger market share of the virus-like particles market in 2021.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the virus-like particles market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Merck & Co., Inc.; GlaxoSmithKline plc.; Pfizer Inc.; Sanofi; Serum Institute of India Pvt. Ltd.; BHARAT BIOTECH; LG Chem; and Dynavax Technologies among others.

Reasons to buy report

To understand the Europe virus-like particles market landscape and identify market segments that are most likely to guarantee a strong return
Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe virus-like particles market
Efficiently plan M&A and partnership deals in Europe virus-like particles market by identifying market segments with the most promising probable sales
Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe virus-like particles market
Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.

Europe Virus-like Particles Market Segmentation

Europe Virus-like Particles Market – By Product type

Hepatitis
Cancer/HPV
Gaucher Disease

Europe Virus-like Particles Market – By Source

Yeast
Insect Cell
Plant
Others

Europe Virus-like Particles Market – By Application

Vaccines
Therapeutics

Europe Virus-like Particles Market – By Country

Europe Virus-like Particles Market – Companies Mentioned

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Virus-like Particles Market – By Product Type

1.3.2 Europe Virus-like Particles Market – By Source

1.3.3 Europe Virus-like Particles Market – By Application

1.3.4 Europe Virus-like Particles Market – By Country

2. Europe Virus-like Particles Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Virus-like Particles Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Experts Opinion

5. Europe Virus-like Particles Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Raising Prevalence of Infectious Viral Diseases

5.1.2 The Growing Role of Virus-Like Particles in Therapeutic Developments and Studies

5.2 Market Restraints

5.2.1 Access of Alternative Technologies for Viral Vaccine Production

5.3 Market Opportunities

5.3.1 Boosting Potential Applications in Therapeutics and Diagnostics

5.4 Future Trends

5.4.1 Ongoing Demand for Innovative and Effective Products

5.5 Impact Analysis

6. Europe Virus-like Particles Market Analysis

6.1 Europe Virus-like Particles Market Revenue Forecast and Analysis

7. Europe Virus-like Particles Market Analysis – by Product Type

7.1 Overview

7.2 Europe Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

7.3 Hepatitis

7.3.1 Overview

7.3.2 Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.4 Cancer/ Human Papillomavirus (HPV)

7.4.1 Overview

7.4.2 Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.5 Gaucher Disease

7.5.1 Overview

7.5.2 Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8. Europe Virus-like Particles Market Analysis – By Source

8.1 Overview

8.2 Europe Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

8.3 Yeast

8.3.1 Overview

8.3.2 Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.4 Plant

8.4.1 Overview

8.4.2 Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.5 Insect Cell

8.5.1 Overview

8.5.2 Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9. Europe Virus-like Particles Market Analysis – By Application

9.1 Overview

9.2 Europe Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

9.3 Vaccines

9.3.1 Overview

9.3.2 Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.4 Therapeutics

9.4.1 Overview

9.4.2 Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Virus-like Particles Market – Country Analysis

10.1 Overview

10.1.1 Europe: Virus-like Particles Market, by Country, 2021 & 2028(%)

10.1.1.1 Germany: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 Germany: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3 Germany: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.4 Germany: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.5 Germany Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2 France: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 France: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3 France: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4 France: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.5 France Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3 UK: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 UK: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3 UK: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4 UK: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.5 UK Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4 Italy: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 Italy: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3 Italy: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.4 Italy: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.5 Italy Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5 Spain: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Overview

10.1.1.5.2 Spain: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3 Spain: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.4 Spain: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.5 Spain Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6 Rest of Europe: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Overview

10.1.1.6.2 Rest of Europe: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3 Rest of Europe: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.4 Rest of Europe: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.5 Rest of Europe Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Europe Virus-like Particles Market

11.1 Impact Assessment of COVID-19 Pandemic

12. Europe Virus-like Particles Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Merck & Co., Inc.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 GlaxoSmithKline plc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Pfizer Inc.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Dynavax Technologies

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Sanofi

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Serum Institute of India Pvt. Ltd.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 BHARAT BIOTECH

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 LG Chem

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)

Table 2. Germany: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 3. Germany: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

Table 4. Germany Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 5. France: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 6. France: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

Table 7. France Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 8. UK: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 9. UK: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

Table 10. UK Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 11. Italy: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 12. Italy: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

Table 13. Italy Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 14. Spain: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 15. Spain: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

Table 16. Spain Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 17. Rest of Europe: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 18. Rest of Europe: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

Table 19. Rest of Europe Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 20. Organic Developments Done by Companies

Table 21. Inorganic Developments Done by Companies

Table 22. Glossary of Terms: Virus-like Particles Market

LIST OF FIGURES

Figure 1. Europe Virus-like particles Market Segmentation

Figure 2. Europe Virus-like particles Market Segmentation, By Country

Figure 3. Europe Virus-like Particles Market Overview

Figure 4. Hepatitis Held the Largest Share of the Product Type Segment in Europe Virus-like particles Market

Figure 5. The UK to Show Significant Growth during Forecast Period

Figure 6. Europe Virus-like Particles Market, Industry Landscape

Figure 7. Europe PEST Analysis

Figure 8. Europe Virus-like Particles Market: Impact Analysis of Drivers and Restraints

Figure 9. Europe Virus-like Particles Market– Revenue Forecast and Analysis to 2028

Figure 10. Europe Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

Figure 11. Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 12. Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 13. Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 14. Europe Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

Figure 15. Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16. Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Europe Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

Figure 20. Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Europe: Virus-like Particles Market, by Key Country – Revenue (2021) (USD Million)

Figure 23. Europe: Virus-like Particles Market, by Country, 2021 & 2028 (%)

Figure 24. Germany: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. France: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. UK: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Italy: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Spain: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Rest of Europe: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Impact of COVID-19 Pandemic in European Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe virus-like particles market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000